Objectif
Our objective is to create within the Community the ditions for emergence of novel therapeutic approaches to neurodegenerative disease and neurotrauma, which represent an urgent socio-eomic and human need. The NeuroNE sortium (22 academic groups, 6 SMEs and 1 management partner in 9 different countries) will take a multi-disciplinary (functional genomics and proteomics, physiology, chemistry, clinical studies) and multi-faceted (disease mechanisms, biology of cell death and survival, regeneration mechanisms, high-throughput screening, gene- and cell-based therapies) approach to this problem. Among the neurodegenerative diseases, we will focus on Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS). Spinal cord injury (SCI) will be the main model for neurotrauma. NeuroNE brings together investigators from different backgrounds (basic scientists, active clinicians and therapeutically-oriented SMEs) to work at all levels on a given disease: post-genomic science, molecular and cell biology, animal models, therapeutic strategies and clinical studies. Professional project management will provide efficient integration, realization of scientific objectives and knowledge management. Common infrastructures include shared NeuroNE-funded core facilities in 7 centres, while our web-based database will serve as a European depository for biological research tools. Training will be provided at several levels: by a competitive program of multi-centre postdoctoral fellowships, by mobility of NeuroNE scientists to other centres and platforms, and by the organization of summer schools and laboratory open days. To feed back the benefits of integration into EU society, we have involved patient organizations from the start, identified associated research groups who will benefit immediately from our infrastructures, and opened network meetings to identified scientists from emerging research centres.
Champ scientifique
- medical and health sciencesbasic medicineneurologydementiaalzheimer
- medical and health sciencesmedical biotechnologycells technologiesstem cells
- medical and health sciencesbasic medicineneurologyparkinson
- medical and health sciencesclinical medicinetransplantation
- medical and health sciencesbasic medicineneurologyamyotrophic lateral sclerosis
Mots‑clés
Appel à propositions
FP6-2003-LIFESCIHEALTH-I
Voir d’autres projets de cet appel
Régime de financement
NoE - Network of ExcellenceCoordinateur
CAMBRIDGE
Royaume-Uni
Voir sur la carte
Participants (27)
LAUSANNE
Voir sur la carte
HEIDELBERG
Voir sur la carte
GOETTINGEN
Voir sur la carte
117 LUND
Voir sur la carte
BASEL
Voir sur la carte
MILANO
Voir sur la carte
HAIFA
Voir sur la carte
PARIS
Voir sur la carte
MUENCHEN
Voir sur la carte
STOCKHOLM
Voir sur la carte
GENEVA 4
Voir sur la carte
MARTINSRIED
Voir sur la carte
ULM
Voir sur la carte
LONDON
Voir sur la carte
ZWIJNAARDE
Voir sur la carte
MADRID
Voir sur la carte
ZURICH
Voir sur la carte
TORINO
Voir sur la carte
Case 931 MARSEILLE
Voir sur la carte
MADRID
Voir sur la carte
MARSEILLE
Voir sur la carte
COLOGNE
Voir sur la carte
PARIS
Voir sur la carte
PADOVA
Voir sur la carte
2313 REHOVOT
Voir sur la carte
CAMBRIDGE
Voir sur la carte
PARIS
Voir sur la carte